ZEB2 and gastric cancer: Additionally, miR-200c overexpression decreases the resistance of GC cells to trastuzumab by suppressing the TGF-β/Smad signaling pathway via downregulating zinc finger E-box-binding homeobox 1 (ZEB1) and ZEB2 expression (130).